18.02.2021 12:30:15
|
Integra LifeSciences Guides FY21 Adj. EPS In Line With View - Quick Facts
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, medical technology company Integra LifeSciences Holdings Corp. (IART) initiated adjusted earnings and revenue guidance for the full-year 2021 and for the first quarter.
For fiscal 2021, the company now projects adjusted earnings in a range of $2.86 to $2.93 per share on revenues between $1.520 billion and $1.535 billion, with organic revenue growth of 12 to 13 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.92 per share on revenues of $1.54 billion for the year. Analysts' estimates typically exclude special items.
For the first quarter, the company expects adjusted earnings in a range of $0.54 to $0.58 per share on revenues between $345 million and $355 million, with organic revenue growth of flat to 3 percent.
The Street is looking for earnings of $0.64 per share on revenues of $359.90 million for the quarter.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Integra LifeSciences Holdings Corp.mehr Nachrichten
Analysen zu Integra LifeSciences Holdings Corp.mehr Analysen
Aktien in diesem Artikel
Integra LifeSciences Holdings Corp. | 21,20 | -0,93% |